Internal Medicine, Hematology & Oncology · Scottsdale, AZ
NPI
1003122573
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
786 services
Medicare patients, 2024
217
Average age 74
Drug cost, 2024
$5.0M
1,387 prescriptions
Company payments, 2025
$152K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amitkumar Mehta was code 99214 (office e&m - established), 261 times for 158 patients. In total Amitkumar Mehta billed 786 services in 15 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 261 | 158 | $57.95 | $15K |
| 99215 Office E&M - Established | Facility | 232 | 113 | $101.70 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 207 | 128 | $12.03 | $2,490 |
| 99233 Hospital E&M - Subsequent | Facility | 32 | 11 | $86.61 | $2,771 |
| 99205 Office E&M - New | Facility | 26 | 26 | $129.05 | $3,355 |
By year: 2022 $52K for 639 services; 2023 $45K for 563 services; 2024 $48K for 786 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amitkumar Mehta prescribed most often to Medicare patients was Acyclovir, with 208 prescriptions and refills. In total Amitkumar Mehta wrote 1,387 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 208 | 233 | 51 | $2,281 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 160 | 178 | 40 | $472 |
| Calquence Acalabrutinib Maleate | 107 | 107 | 12 | $1.3M |
| Prednisone Generic | 82 | 82 | 27 | $175 |
| Imbruvica Ibrutinib | 71 | 71 | Under 11 | $1.0M |
| Venclexta Venetoclax | 61 | 61 | Under 11 | $492K |
| Oxycodone Hcl Generic | 41 | 41 | 21 | $472 |
| Gabapentin Generic | 40 | 53 | Under 11 | $669 |
| Brukinsa Zanubrutinib | 39 | 39 | Under 11 | $452K |
| Dexamethasone Generic | 37 | 37 | 18 | $498 |
| Ondansetron Hcl Generic | 34 | 34 | 29 | $453 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 29 | 29 | Under 11 | $123K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | Under 11 | $748 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 22 | 22 | Under 11 | $125K |
| Revlimid Lenalidomide | 21 | 21 | Under 11 | $337K |
Brand drugs: 430 claims; generic drugs: 957 claims; opioid claims: 96.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amitkumar Mehta $152K ($150K in general payments such as food, travel and fees and $1,492 for research) from 19 companies. The largest payer was Incyte Corporation with $42K.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 18 | $42K |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $38K |
| Adc Therapeutics America, Inc. | 12 | $22K |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $19K |
| Kite Pharma, Inc. GILD | 9 | $16K |
| Genentech USA, Inc. ROG.SW | 4 | $5,813 |
| Pfizer Inc. PFE | 2 | $2,520 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $2,100 |
| AstraZeneca UK Limited AZN | 1 | $2,050 |
| F. Hoffmann-La Roche AG ROG.SW | 2 | $1,492 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.